ENTRY       D10331                      Drug
NAME        Ozanezumab (USAN/INN)
FORMULA     C6446H10016N1712O2010S48
EXACT_MASS  145104.076
MOL_WEIGHT  145193.8836
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYWMHWVRQA PGQGLEWIGN INPSNGGTNY
            NEKFKSKATM TRDTSTSTAY MELSSLRSED TAVYYCELMQ GYWGQGTLVT VSSASTKGPS
            VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL QSSGLYSLSS
            VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL AGAPSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS
            CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            DIVMTQSPLS NPVTLGQPVS ISCRSSKSLL YKDGKTYLNW FLQRPGQSPQ LLIYLMSTRA
            SGVPDRFSGG GSGTDFTLKI SRVEAEDVGV YYCQQLVEYP LTFGQGTKLE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H140-H196, H216-L219, H222-H'222, H225-H'225, H257-H317, H363-H421, H'22-H'96, H'140-H'196, H'216-L'219, H'257-H'-317, H'363-H'421, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Nogo protein inhibitor
  TYPE      Monoclonal antibody
COMMENT     Treatment of ALS and multiple sclerosis
TARGET      RTN4 [HSA:57142] [KO:K20720]
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Cellular process
               Membrane trafficking
                RTN4
                 D10331  Ozanezumab (USAN/INN)
DBLINKS     CAS: 1310680-64-8
            PubChem: 172232425
///
